Similar articles

• The Study of Tamoxifen and Raloxifene (STAR trial) for the prevention of breast cancer.

  Kelminski A. Kelminski A. Hawaii Med J. 2002 Sep;61(9):209-10. Hawaii Med J. 2002. PMID: 12422387 Clinical Trial. No abstract available.
• How do we interpret the results of the Breast Cancer Prevention trial?

  Margolese RG. Margolese RG. CMAJ. 1998 Jun 16;158(12):1613-4. CMAJ. 1998. PMID: 9645175 Free PMC article. No abstract available.
• Tamoxifen and breast cancer prevention: what should you tell your patients?

  Goel V. Goel V. CMAJ. 1998 Jun 16;158(12):1615-7. CMAJ. 1998. PMID: 9645176 Free PMC article. Review. No abstract available.
• Chemoprevention of breast cancer: recommendations and rationale.

  [No authors listed] [No authors listed] Am Fam Physician. 2003 Mar 15;67(6):1309-14. Am Fam Physician. 2003. PMID: 12674459 Review. No abstract available.
• DM effort seeks to improve outcomes through prevention, early detection of breast cancer.

  [No authors listed] [No authors listed] Dis Manag Advis. 2000 Sep;6(9):140-4, 132. Dis Manag Advis. 2000. PMID: 11125466